Pyodermas and Bacterial Toxin-mediated Syndromes
James R. Treat
Children's Hospital of Philadelphia and Dermatology Section, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA
Search for more papers by this authorWarren R. Heymann
Division of Dermatology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Camden, NJ, USA
Search for more papers by this authorSteven M. Manders
Division of Dermatology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Camden, NJ, USA
Search for more papers by this authorJames R. Treat
Children's Hospital of Philadelphia and Dermatology Section, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA
Search for more papers by this authorWarren R. Heymann
Division of Dermatology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Camden, NJ, USA
Search for more papers by this authorSteven M. Manders
Division of Dermatology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Camden, NJ, USA
Search for more papers by this authorPeter Hoeger
Search for more papers by this authorVeronica Kinsler
Search for more papers by this authorAlbert Yan
Search for more papers by this authorJohn Harper
Search for more papers by this authorArnold Oranje
Search for more papers by this authorChristine Bodemer
Search for more papers by this authorMargarita Larralde
Search for more papers by this authorVibhu Mendiratta
Search for more papers by this authorDiana Purvis
Search for more papers by this authorSummary
Cutaneous bacterial infections in children are common but important to recognize as they can lead to significant sequelae. Staphylococcus aureus (SA) and Group A Streptococcus (GAS) are the most common causes of infection. Skin infection with these bacteria typically presents with pustules and crusting and can be recognized clinically. SA and GAS most commonly cause localized cutaneous infections but can lead to serious systemic diseases such as cellulitis, staphylococcal skin syndrome and necrotizing fasciitis. It has become more important to consider culturing the skin to establish bacterial sensitivities due to the increase in SA that is meticillin resistant.
References
-
Steer A, Danchin M, Carapetis J. Group A streptococcal infections in children. J Pediatr Child Health 2007; 43: 209–13.
10.1111/j.1440-1754.2007.01051.x Google Scholar
- Martin J, Green M. Group A streptococcus. Semin Pediatr Infect Dis 2006; 17: 140–8.
- Burnett A, Domachowske J. Therapeutic considerations for children with invasive group A streptococcal infections: a case series report and review of the literature. Clin Pediatr 2007; 46: 550–5.
- Manders S. Toxin-mediated streptococcal and staphylococcal disease. J Am Acad Dermatol 1998; 39: 383–98.
- Iwatsuki K, Yamasaki O, Morizane S, Oono T. Staphylococcal cutaneous infections: invasion, evasion, and aggression. J Dermatol Sci 2006; 42: 203–14.
- Deurenberg R, Stobberingh E. The evolution of Staphylococcus aureus. Infect Genet Evol 2008; 8: 747–63.
- Lopez MA, Cruz AT, Kowalkowski MA, Raphael JL. Trends in resource utilization for hospitalized children with skin and soft tissue infections. Pediatrics 2013; 131: e718–25.
- Kil E, Heymann W, Weinberg J. Methicillin-resistant Staphylococcus aureus: an update for the dermatologist. Cutis 2008; 81: 227–32, 247–52.
- Gorwitz R. A review of community-associated methicillin resistant Staphylococcus aureus skin and soft tissue infections. Pediatr Infect Dis J 2008; 27: 1–7.
- Stryjewski M, Chambers H. Skin and soft tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008; 46: S368–77.
- Patel, A, Hill E, Simpson, E, Hanafin J. Reversion of methicillin-resistant Staphylococcus aureus skin infections to methicillin-susceptible. AMA Dermatol 2013; 149: 1167–71.
- Fritz SA1, Hogan PG, Camins BC et al. Mupirocin and chlorhexidine in Staphylococcus aureus in patients with community-onset skin and soft tissue infections. Antimicrob Agents Chemother 2013; 57: 559–68.
- Milstone AM, Elward A, Song X et al. Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, cross-over trial. Lancet 2013; 381: 1099–106.
References
- Manders S. Toxin-mediated streptococcal and staphylococcal disease. J Am Acad Dermatol 1998; 39: 383–98.
-
Steer A, Danchin M, Carapetis J. Group A streptococcal infections in children. J Pediatr Child Health 2007; 43: 209–13.
10.1111/j.1440-1754.2007.01051.x Google Scholar
- Gorwitz R. A review of community-associated methicillin resistant Staphylococcus aureus skin and soft tissue infections. Pediatr Infect Dis J 2008; 27: 1–7.
- Johnson RC, Ellis MW, Lanier JB et al. Correlation between nasal microbiome composition and remote purulent skin and soft tissue infections. Infect Immun 2015; 83: 802–11.
- Kumar N, David MZ, Boyle-Vavra S et al. High Staphylococcus aureus colonization prevalence among patients with skin and soft tissue infections and controls in an urban emergency department. J Clin Microbiol 2015; 53: 810–15.
- Iverson SA, Brazil AM, Ferguson JM et al. Anatomical patterns of colonization of pets with staphylococcal species in homes of people with methicillin-resistant Staphylococcus aureus (MRSA) skin or soft tissue infection (SSTI). Vet Microbiol 2015; 176: 202–8.
- Kil E, Heymann W, Weinberg J. Methicillin-resistant Staphylococcus aureus: an update for the dermatologist. Cutis 2008; 81: 227–32, 247–52.
- McNeil JC, Hulten KG, Kaplan SL, Mason EO. Decreased susceptibilities to retapamulin, mupirocin, and chlorhexidine among Staphylococcus aureus isolates causing skin and soft tissue infections in otherwise healthy children. Antimicrob Agents Chemother 2014; 58: 2878–83.
References
-
Steer A, Danchin M, Carapetis J. Group A streptococcal infections in children. J Pediatr Child Health 2007; 43: 209–13.
10.1111/j.1440-1754.2007.01051.x Google Scholar
- Cole C, Gazewood J. Diagnosis and treatment of impetigo. Am Fam Physician 2007; 75: 859–64.
- Mathes EF, Oza V, Frieden IJ et al. “Eczema coxsackium” and unusual cutaneous findings in an enterovirus outbreak. Pediatrics 2013; 132: e149–57.
- Parks T, Smeesters PR, Steer AC. Streptococcal skin infection and rheumatic heart disease. Curr Opin Infect Dis 2012; 25: 145–53.
- Lopez F, Lartchenko S. Skin and soft tissue infections. Infect Dis Clin North Am 2006; 20: 759–72.
- Kroshinsky D, Grossman M, Fox L. Approach to the patient with presumed cellulitis. Semin Cutan Med Surg 2007; 26: 168–78.
- Neri I, Montanari F, Baraldi C et al. Erysipelas as a superinfection of an oral lymphangioma. J Pediatr 2014; 165: 205.
- Ellerbe D, Parsons D, Cook P. Botryomycosis: improved therapy for a difficult infection. Int J Pediatr Otorhinolaryngol 1997; 41: 363–9.
- Bonifaz A, Carrasco E. Botryomycosis. Int J Dermatol 1996; 35: 381–8.
- Nguyen R, Beardmore G. Blastomycosis-like pyoderma: successful treatment with low-dose acitretin. Australas J Dermatol 2005; 46: 97–100.
- Sawalka S, Phiske M, Jerajani H. Blastomycosis-like pyoderma. Indian J Dermatol Venereol Leprol 2007; 73: 117–19.
- Bingol-Kologlu M, Yildiz R, Alper B et al. Necrotizing fasciitis in children: diagnostic and therapeutic aspects. J Pediatr Surg 2007; 42: 1892–7.
- Hsieh WS, Yang PH, Chao HC, Lai JY. Neonatal necrotizing fasciitis: a report of three cases and review of the literature. Pediatrics 1999; 103: e53.
- Manders S. Toxin-mediated streptococcal and staphylococcal disease. J Am Acad Dermatol 1998; 39: 383–98.
- Scheinfeld N. Is blistering distal dactylitis a variant of bullous impetigo? Clin Exp Dermatol 2007; 32: 314–16.
- Jongen J, Eberstein A, Peleikas H et al. Perianal streptococcal dermatitis: an important differential diagnosis in pediatric patients. Dis Colon Rectum 2008; 51: 584–7.
- Honig P, Frieden I, Kim H, Yan A. Streptococcal intertrigo: an underrecognized condition in children. Pediatrics 2003; 112: 1427–9.
References
- Manders S. Toxin-mediated streptococcal and staphylococcal disease. J Am Acad Dermatol 1998; 39: 383–98.
- Anzai H. Production of low titers of anti-desmoglein 1 IgG autoantibodies in some patients with staphylococcal scalded skin syndrome. J Invest Dermatol 2006; 126: 2139–41.
- Li MY, Hua Y, Wei GH, Qiu L. Staphylococcal scalded skin syndrome in neonates: an 8-year retrospective study in a single institution. Pediatr Dermatol 2014; 31: 43–7.
- Braunstein I, Wanat KA, Abuabara K et al. Antibiotic sensitivity and resistance patterns in pediatric staphylococcal scalded skin syndrome. Pediatr Dermatol 2014; 31: 305–8.
- Iwatsuki K, Yamasaki O, Morizane S, Oono T. Staphylococcal cutaneous infections: invasion, evasion, and aggression. J Dermatol Sci 2006; 42: 203–14.
- Patrizi A, Raone B, Savoia F et al. Recurrent toxin-mediated perineal erythema. Arch Dermatol 2008; 144: 239–43.